相关实验视频
Updated: Jun 13, 2025

05:58
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
40.1K
对于罕见遗传性肌肉消耗疾病患者的物理治疗干预:系统性审查和元分析
1Department of Health Rehabilitation Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, SAU.
Cureus
|September 9, 2024
概括
物理治疗在罕见的遗传肌肉消耗疾病 (MWDs) 中显著改善运动功能. 干预措施,特别是运动计划,提高了6分钟步行测试 (6MWT) 的表现,提高了患者的生活质量.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 遗传学 是一个遗传学.
背景情况:
- 罕见的遗传性肌肉消耗疾病 (MWDs) 导致显著的运动障碍,影响患者的生活质量.
- 有效的管理策略对于患有MWD的人来说至关重要.
- 物理治疗干预措施在解决运动缺陷方面表现有前途.
研究的目的:
- 系统地审查和元分析物理治疗对罕见遗传MWD运动结果的影响.
- 评估各种物理治疗干预措施的有效性.
- 确定改善MWD患者运动功能的最佳策略.
主要方法:
- 一项全面的文献搜索确定了随机对照试验 (RCT) 和队列研究.
- 6分钟步行测试 (6MWT) 是主要的结局措施.
- 随机效应模型用于元分析,计算平均差异 (MD) 和95%置信区间 (CI).
主要成果:
- 包括9项研究,证明物理治疗对MWD患者的积极影响.
- 对RCT的分析显示,6MWT的性能显著改善 (MD:-35.25m;95%CI:-54.14至-16.37).
- 队列研究也显示了显著的6MWT改善 (MD: -10.00m;95%CI: -11.07至 -8.93),在两种分析中异质性很低.
结论:
- 物理治疗干预显著提高了罕见遗传MWD的运动功能,由改善的6MWT性能证明.
- 运动和强化物理治疗方案特别有效.
- 应将定制的物理治疗策略整合到MWD管理中,以改善运动结果和生活质量.
相关概念视频
Disorders of the Skeletal Muscle
904
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
904
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
661
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
661
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Skeletal Muscle Relaxants: Adverse Effects
348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
348

